The Marketing Alliance, Inc. (OTC: MAAL) (“TMA”), today announced
that its Board of Directors authorized a $0.21 per share cash dividend
for shareholders of record on December 12, 2014, to be paid on or about
January 30, 2015.
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a
biopharmaceutical company developing PRX302 for the treatment of the
symptoms of benign prostatic hyperplasia (BPH, enlarged prostate) and
for the treatment of localized low to intermediate risk prostate cancer,
today announced financial results for the three and nine months ended
September 30, 2014.
Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La
Jolla), a leader in the development of innovative therapies intended to
significantly improve outcomes in patients suffering from
life-threatening diseases, today reported third quarter and year-to-date
2014 financial results and highlighted recent corporate progress and
Seagate Technology (NASDAQ:STX) to participate in the following investor
UBS Global Technology Conference
Wednesday, November 19, 2014
Presentation – 9:15 AM PT / 12:15 PM ET
Live and archived audio webcast of this event
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.